wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42693130-852DF9B2-90B2-447A-AED0-524669BE803D
Q42693130-852DF9B2-90B2-447A-AED0-524669BE803D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42693130-852DF9B2-90B2-447A-AED0-524669BE803D
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.
P2860
Q42693130-852DF9B2-90B2-447A-AED0-524669BE803D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42693130-852DF9B2-90B2-447A-AED0-524669BE803D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38f987cf13db8188ee470ad09c12bcad695bdf68
P2860
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.